Skip to main content
. 2023 Mar 31;13:106. doi: 10.1038/s41398-023-02399-1

Fig. 4. KAT II inhibition at the beginning of dark phase improves sleep during the subsequent light phase in ECon and EKyn offspring.

Fig. 4

Adult ECon and EKyn offspring were treated with vehicle or PF-04859989 (30 mg/kg) at Zeitgeber time (ZT) 12. A 6-h bins of REM duration in ECon, sexes combined (treatment × ZT interaction F(3, 21) = 3.451, P < 0.05). B 6-h bins of NREM duration in ECon, sexes combined (treatment × ZT interaction F(3, 21) = 4.355, P < 0.05). C 6-h bins of wake duration in ECon, sexes combined (treatment × ZT interaction F(3, 21) = 5.087, P < 0.01). D NREM delta spectral power during dark phase in ECon, sexes combined. E NREM delta spectral power during light phase in ECon, sexes combined. F 6-h bins of REM duration in EKyn, sexes combined. G 6-h bins of NREM duration in EKyn, sexes combined (treatment effect F(1, 7) = 5.594, P = 0.05, treatment × ZT interaction F(3, 21) = 3.290, P < 0.05). H 6-h bins of wake duration in EKyn, sexes combined (treatment effect F(1, 7) = 6.926, P < 0.05). I NREM delta spectral power during dark phase in EKyn, sexes combined (treatment × frequency interaction F(7, 49) = 3.861, P < 0.01). J NREM delta spectral power during light phase in EKyn, sexes combined (treatment effect F(1, 7)= 13.29, P < 0.01, treatment × frequency interaction F(7, 49) = 3.050, P < 0.01). Data are mean ± SEM. Percent change from vehicle treatment calculations are shown by arrows. Two-way RM ANOVA: ^P < 0.05, ^^P < 0.01 with Fisher’s LSD post hoc test: *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001. N = 8 per group.